Induction of human autologous cytotoxic T lymphocytes against minced tissues of glioblastoma multiforme
- 1 February 1996
- journal article
- Published by Journal of Neurosurgery Publishing Group (JNSPG) in Journal of Neurosurgery
- Vol. 84 (2) , 258-263
- https://doi.org/10.3171/jns.1996.84.2.0258
Abstract
The authors induced autologous cytotoxic T lymphocytes (CTLs) directly from peripheral blood lymphocytes by preparing a coculture of minced tissue fragments of glioblastoma multiforme (GBM) with interleukins-1, -2, -4, and -6 and interferon-gamma in RHAM alpha medium containing 5% autologous plasma for 2 weeks. At the end of this period, the frequencies of CD3+, CD4+, CD8+, and CD16+ lymphocytes were 95% to 99%, 40% to 62%, 37% to 38%, and 0.2%, respectively. The lymphocytes killed 82% to 100% of the GBM cells within 48 hours at an effector-to-target cell ratio of 1.67, whereas in a separate coculture, autologous lymphokine-activated killer (LAK) cells killed only 33% of GBM cells under the same conditions. The lymphocytes showed no cytotoxicity against LAK-sensitive Daudi cells, natural killer-sensitive K562 cells or autologous fibroblasts grown from the brain tumor, although they did show slight cytotoxicities against allogeneic GBM cell lines. These results lead the authors to suggest that the lymphocyte population contains specific CTLs for autologous brain tumor cells and that these CTLs could be effective in adoptive immunotherapy to combat brain tumor.Keywords
This publication has 28 references indexed in Scilit:
- In Vitro Expansion of Tumor-Specific, HLA-Restricted Human CD8+ Cytolytic T LymphocytesCellular Immunology, 1994
- Inhibition of Human Colon Cancer Growth by Antibody-Directed Human LAK Cells in SCID MiceScience, 1993
- Cytokine regulation of cell-to-cell interactions in lymphokine-activated killer cell cytotoxicity in vitroCancer Immunology, Immunotherapy, 1993
- T Cell Recognition of Human Tumors: Implications for Molecular Immunotherapy of CancerClinical Immunology and Immunopathology, 1993
- Additive effects of antitumor drugs and lymphokine-activated killer cell cytotoxic activity in tumor cell killing determined by lactate-dehydrogenase-release assayCancer Immunology, Immunotherapy, 1992
- Role of MHC class‐i antigens and the CD3 complex in the lysis of autologous human tumours by T‐cell clonesInternational Journal of Cancer, 1987
- A Progress Report on the Treatment of 157 Patients with Advanced Cancer Using Lymphokine-Activated Killer Cells and Interleukin-2 or High-Dose Interleukin-2 AloneNew England Journal of Medicine, 1987
- A New Approach to the Adoptive Immunotherapy of Cancer with Tumor-Infiltrating LymphocytesScience, 1986
- Observations on the Systemic Administration of Autologous Lymphokine-Activated Killer Cells and Recombinant Interleukin-2 to Patients with Metastatic CancerNew England Journal of Medicine, 1985
- The in vitro generation and sustained culture of nude mouse cytolytic T-lymphocytes.The Journal of Experimental Medicine, 1979